Large-scale proteomics in population-based studies may contribute to a better understanding of diseases

by

In an article revealed in Nature, scientists from deCODE Genetics, a subsidiary of the pharmaceutical company Amgen, demonstrated how plasma proteomics can contribute to a better understanding of diseases.

Leave A Comment

Your email address will not be published. Required fields are marked *